empagliform12.5&500mg30tab

Empagliform is a combination medication used to improve glycemic control in adults with type 2 diabetes mellitus. It combines Empagliflozin, an SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream, and Metformin, a biguanide that decreases glucose production in the liver and improves insulin sensitivity. This dual-action approach provides comprehensive management for patients who require both agents for effective blood sugar regulation. It is intended to be used alongside diet and exercise to achieve optimal therapeutic outcomes and reduce the risk of cardiovascular complications associated with diabetes.